Original Research
Published on 03 Jul 2020
The Delivery of α1-Antitrypsin Therapy Through Transepidermal Route: Worthwhile to Explore
in Experimental Pharmacology and Drug Discovery
Frontiers in Pharmacology
doi 10.3389/fphar.2020.00983
- 9,041 views
- 11 citations


![A new small molecule DHODH-inhibitor [KIO-100 (PP-001)] targeting activated T cells for intraocular treatment of uveitis — A phase I clinical trial](https://www.frontiersin.org/files/myhome article library/1023224/1023224_Thumb_400.jpg)